凱普生物(300639.SZ):公司及子公司獲得授予一項發明專利權
格隆匯6月11日丨凱普生物(300639.SZ)公佈,近日,公司以及全資子公司廣東凱普科技智造有限公司(以下簡稱"凱普智造")等收到國家知識產權局下發的《授予發明專利權通知書》,發明創造名稱為一種核酸PCR擴增雜交反應儀及擴增雜交一體機。
本發明涉及分子生物學技術領域和核酸擴增雜交設備技術領域,提供了一種核酸PCR擴增雜交反應儀及擴增雜交一體機。核酸PCR擴增雜交反應儀包括:機座、機殼、機蓋和反應模塊。核酸PCR擴增雜交反應儀將核酸擴增儀、雜交儀的反應室整合到一個全封閉的立體設備中,PCR擴增雜交反應裝置帶有蓋子,可以將PCR反應室和雜交反應室圍成密封空間,有效避免了氣溶膠污染。核酸PCR擴增雜交反應儀具有多個用於安放PCR擴增雜交反應裝置的安裝槽,每個安裝槽相互隔開,避免了多個擴增反應的相互干擾,提高了擴增反應的準確率,此外,該設備便捷度高,能滿足單一或多個樣品同時分析。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.